Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil
NCT ID: NCT05197647
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1085 participants
OBSERVATIONAL
2022-01-25
2024-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Long COVID-19 on the Health and Quality of Life of Military Personnel (Active or Retired) and Their Families
NCT05200832
Brief COVID-19 Intervention for People With Serious Mental Illness and Co-Morbid Medical Conditions
NCT05467982
MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain
NCT04556565
Investigating the Impact of Professional Development Coaching for Faculty
NCT05036993
COVID-19 and Mental Health
NCT04407195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with mild COVID-19
Patients with symptomatic COVID-19 disease not requiring hospitalization.
Patients with symptomatic COVID-19 disease not requiring hospitalization.
Patients with symptomatic COVID-19 disease not requiring hospitalization.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients with symptomatic COVID-19 disease not requiring hospitalization.
Patients with symptomatic COVID-19 disease not requiring hospitalization.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positive polymerase chain reaction (PCR) test for SARS-CoV-2;
* At least one of the following symptoms: fever, cough, sneezing, dyspnea, fatigue, smell alteration, rhinorrhea, sore throat, myalgia, arthralgia, diarrhea;
* Outpatient COVID-19 care at the moment of enrollment (without indication for in-hospital care).
Exclusion Criteria
* Absence of proxy for patients with communication difficulties;
* Absence of telephone contact;
* Refusal or withdrawal of agreement to participate;
* Previous enrollment in the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Moinhos de Vento
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Regis Rosa, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Moinhos de Vento
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Silvestre Santé
Rio Branco, Acre, Brazil
Hospital Enseada Prime
Vitória, Espírito Santo, Brazil
Hospital do Coração do Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
Hospital Metropolitano Célio de Castro
Belo Horizonte, Minas Gerais, Brazil
Instituto Horizonti
Belo Horizonte, Minas Gerais, Brazil
Hospital Universitário de Ponta Grossa
Ponta Grossa, Paraná, Brazil
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Vila Nova
Porto Alegre, Rio Grande do Sul, Brazil
Instituto Procardio
Joinville, Santa Catarina, Brazil
Hospital Leo Orsi
Itapetininga, São Paulo, Brazil
Hospital de Clínicas de Ribeirão Preto
Ribeirão Preto, São Paulo, Brazil
Hospital Alemão Oswaldo Cruz
São Paulo, São Paulo, Brazil
Hospital do Coração
São Paulo, São Paulo, Brazil
Hospital Santa Paula
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rover MM, Trott G, Scolari FL, Silva MMDD, Souza D, Santos RDRMD, Dagnino APA, Mesquita Neto J, Estivalete GP, Kozesinski-Nakatani AC, Marcolino MS, Barreto BB, Schvartzman PR, Antonio ACP, Robinson CC, Falavigna M, Biolo A, Polanczyk CA, Rosa RG. Health-Related Quality of Life and Long-Term Outcomes after Mildly Symptomatic COVID-19: The Post-COVID Brazil Study 2 Protocol. Arq Bras Cardiol. 2023 Sep;120(9):e20220835. doi: 10.36660/abc.20220835. English, Portuguese.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pos-COVID Brasil 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.